In contrast, studies on exosomes showed that exposure of HCC cells to sorafenib increases the expression of linc VLDLRs in exosomes related to the cells, and incubation with these exosomes inhibits cell death in response to the drug, and increases linc VLDLR expression, leading to drug resistance [120]. Here, VLDLR is linked to hepatocellular carcinoma.